Flow cytometric analysis of myeloid and lymphoid cells extracted from C57BL/6 mouse melanoma model using SM1 Igf2bp1-KO and CRISPR/Cas9 control showed increased accumulation of some immune cell subsets in the tumor microenvironment. Here, IGF2BP1 is linked to neoplasm.